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improve alcohol treatment outcome
Anette Søgaard Nielsen1,2* and Bent Nielsen1,2Abstract
This article describes the design, implementation, and evaluation of a clinical pathway system in a two-cohort
quasi-experimental study before and after implementation, controlling for confounders. The main outcome measures
were retention in care and sensible alcohol use (defined as abstinent or drinking no more than 21 standard drinks
per week). Patients with harmful alcohol use or dependence as their primary problem who were seeking psychosocial
treatment at one of four alcohol clinics in Denmark participated in the study. After implementation of the clinical
pathway system, which incorporated a structured intake, a referral and independent follow-up system, checklists,
audit, and feedback, there was no change in length of stay, but significantly more patients had a good clinical
outcome (stopped or moderated their consumption) at the end of treatment (OR = 1.9; 1.2–3.1). The study documents
the feasibility of using a clinical pathway framework, incorporating a local monitoring system, checklists, audit,
and feedback to enhance treatment quality and improve outcomes for alcohol use disorders.
Keywords: Alcoholism, Outpatient clinics, Clinical pathway, Local monitoring, OutcomeIntroduction
The quality of treatment for alcohol use disorders varies
widely [1,2], and how treatment quality might be im-
proved and monitored has been a subject of discussion
for decades [3]. In 2006, the Institute of Medicine rec-
ommended the introduction of substance use treatment
systems to strengthen infrastructure and quality assur-
ance through using valid and reliable patient-assessment
instruments, building the evidence base for effective
treatment methods, and continuously monitoring treat-
ment processes and outcomes [4]. Clinical pathways—
that is, structured systems for standardizing care—have
the potential to reduce variability in treatment quality
and improve systematic data collection for continuous
quality improvement [5,6].
In many countries, outpatient psychosocial treatment
is the primary vehicle for delivering services for alcohol
problems. The treatment is often delivered by relatively
small treatment facilities staffed by social workers and
therapists. Some health-care areas have a tradition for
the development of clinical pathways. Within the medical* Correspondence: ansnielsen@health.sdu.dk
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article, unless otherwise stated.field, for instance, there is a tradition for the systematic
collection of patient data, the delivery of evidence-based
treatment, and systematic quality development. This trad-
ition is not present to the same degree in the alcohol treat-
ment field, at least not in Denmark. Although staff
working in the alcohol field in Denmark are generally well
trained, treatment is often delivered as individual treat-
ment courses by a single therapist behind “a closed door,”
even when the treatment facility has a number of staff.
The documentation of therapy falls to the therapist and is
often inconsistent, lacking a standardized approach, and
hinging on what the therapist considers is important to
document. Hence, it is not always easy to know what is
actually going on during treatment and to what extent
specific elements of treatment feature in the treatment
course. The implementation of new strategies and rou-
tines may also be a challenge and are even more diffi-
cult to assess.
From a quality improvement perspective, small clinics
delivering treatment for alcohol problems would be con-
sidered microsystems. However, when clinics work together
in an organized system, it becomes possible to implement
clinical pathways and evaluate the impact of specific system
interventions. This article describes the development, im-
plementation, and evaluation of a clinical pathway within aCentral. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
Treatment course Process standards attached 
Acute treatment of withdrawal 
symptoms (if needed)
Assessment by the means of ASI 
Referral to treatment, based on the 
assessment results
Treatment delivery in three months
(Therapy, supplemented with 
patient education)
Evaluation of treatment course and 
data collection
Treatment delivery in three months
(Therapy, supplemented with 
patient education)
Evaluation of treatment course and 
data collection
Treatment delivery in three months
(Therapy, supplemented with
patient education)
Evaluation of treatment course and 
data collection
Treatment delivery in three months
(Therapy, supplemented with 
patient education)
Termination of treatment and data 
collection
Standards 1, 2 & 4
Standard 3
Standards 1, 2 & 4
Standard 3
Standards 1, 2 & 4
Standard 3
Standard 1, 2 & 4
Standard 5 
Figure 1 Clinical pathway in the alcohol treatment facilities in
funen.
Nielsen and Nielsen Addiction Science & Clinical Practice  (2015) 10:7 Page 2 of 7Danish alcohol treatment institution consisting of four
community-based outpatient clinics with roughly 50 staff
members in total.
Research methods
The participating clinics
The present study was conducted in the county of Funen,
Denmark. A public health organization consisting of four
outpatient alcohol treatment clinics delivered services to
the whole county, whose population is about 480,000
(about 10% of the Danish population). The four clinics
were scattered across the county. Most patients sought
treatment at the nearest clinic. In all the clinics, treatment
was carried out by an interdisciplinary team of nurses,
psychiatrists, and social workers. The treatment options at
the clinics were in principle the same. In all four clinics,
the patients were offered initial detoxification as needed,
and thereafter assessed by a structured interview. The
backbone of the interview was the Addiction Severity
Index (ASI) [7]. Patients were also asked how many days
in the past 30 days they had consumed more than three
standard units of alcohol. All data from the interviews
were stored in a clinical database. After reviewing the ASI
data, the psychiatrists referred the patients to one of the
clinic’s treatment interventions. Treatment staff were well
trained, delivering the preferred treatment approach in
which they had been trained. Staff practice was closely
monitored. Since the clinics were all part of the same
organization, they shared management, and staff covered
for each other in case of illness and vacation. The present
study focused not on the specific content of treatment but
rather on the systemic aspects of service delivery.
Development of a clinical pathway
A year-long monitoring program of all treatment courses
at the clinics revealed two common quality problems
across the clinics: patient dropout from treatment was
generally high during the first 6 months of treatment,
and relatively few clients reduced their drinking to below
the Danish recommended level for sensible drinking
(maximum of 21 standard drinks per week) during the
treatment course.
The quality problems were presented to staff and man-
agement, and a quality improvement unit within the treat-
ment system was set up and run by an audit team. The
audit team consisted of management, staff representatives
from all participating clinics, and the psychiatrist. Three
staff working groups were also set up. All the clinics were
represented in each working group in order to secure
homogeneity across clinics. Staff and management identi-
fied areas that needed to be developed. Within these areas,
the working groups were to identify and describe key
process standards that they believed could improve patient
retention and outcomes. In order to ensure that the staffcould talk freely and frankly, and to secure local owner-
ship of the process and the proposals developed, manage-
ment was not part of the working groups. The working
groups met approximately five times during the following
6 months. All meetings were half day-meetings.
The process standards developed by the working groups
were presented to the entire staff and management at
the clinics during a full-day meeting, and a clinical path-
way was designed based on the proposals and identified
service-specific timelines. The clinical pathway, with five
process standards attached, is shown in Figure 1. All staff
agreed to be faithful to the structure and content of the
pathway. The audit team oversaw implementation of the
standards.
Process standards
The content of the process standards was based on pub-
lished research, and the core performance standards
developed by the Washington Circle Group [8,9] were
particularly taken into account. In all, five process standards
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scribed below.
Standard 1: Documentation of therapist adherence to
clinical guidelines
The clinics had developed clinical guidelines for the deliv-
ery of cognitive-behavioral therapy, systemic family ther-
apy, and supportive counseling. Knowing that therapists
often fail to adhere to such clinical guidelines [10], one
process standard further required that use of the guide-
lines should be documented in a standardized way in the
case notes for all therapy sessions.
Standard 2: Patient education
In contemporary alcohol treatment, patients are expected
to make their own informed choices and take responsibil-
ity for changing their drinking habits. Patient education
during treatment ensures that patients have the informa-
tion they need in order to make the necessary choices [8].
Consequently, a standard for patient education was estab-
lished. The aim of the standard was to ensure that patient
education was delivered when needed. The standard de-
scribed how the staff should deliver information about
how alcohol affects people, the risk of incurring an alcohol
use disorder, and what the symptoms of dependency are.
The patient education material also described alcohol’s
possible damage to health, social life, and to the children
in a family. The standard specified how the information
should be given in a nonthreatening way and be made as
personalized as possible.
Standard 3: continuity of care
To ensure that the treatment course was on the right
track, regular assessment, feedback to the patient, and dis-
cussion of care should occur. This standard stated that at
least once every 3 months, the therapist should present a
status report at the staff meeting, based on an ASI inter-
view previously conducted with the patient. Treatment
course and progress would then be discussed with the
patient and with colleagues.
Standard 4: retention in care
Clinical research generally shows that retention in treat-
ment is associated with better client outcomes and that
the prognosis is particularly good with patients who re-
main in treatment for 6 months [11]. This standard de-
scribed strategies to increase retention (e.g., reduction of
waiting time early in treatment) and specified strategies
for contacting patients who missed appointments (e.g.,
phone calls and letters) [12].
Standard 5: termination
A satisfactory conclusion of treatment also seems to be
vital [13]. Standard 5 describes how the patient andtherapist should decide together when it is time to end
treatment. Ideally, it is the patient who initiates termin-
ation, but if this does not happen and the patient has
remained sober for a reasonable period of time, it is the ther-
apist’s responsibility to bring up the topic of termination.
The working groups described all five standards in the
following terms: process, structure, and expected outcome.
Each standard described what was supposed to be carried
out (process); by whom, when, and where (structure); and
what result was intended (outcome). Furthermore, guid-
ance notes were drawn up by the working groups, describ-
ing the rationale and the evidence base for the standards,
which were distributed to colleagues.Process standards checklist
When these process standards were implemented, the audit
team introduced a checklist to be completed for each
patient to document whether and when the standards
had been carried out. The use of such checklists is an
important implementation tool and data source in clinical
pathways [14]. The checklist also served as a reminder to
minimize lapses in standards during the course of treat-
ment. Data from the checklist allowed performance of
good practice standards to be linked to client outcomes.Evaluating the clinical pathway
Since national monitoring programs were unavailable,
we opted for a local outcome monitoring system in which
data were collected during treatment [15]. The monitoring
system was in place both before and after implementation
of the clinical pathway. The data in the monitoring system
consisted of details from ASI interviews completed with
all patients at intake and at 3, 6, and 12 months after
treatment initiation, or at treatment termination. The
data yielded a multidimensional assessment of the patient’s
functional capacity in the preceding month. ASI ratings
were derived for seven areas of functioning: medical, em-
ployment, alcohol, drug, legal, family/social network, and
psychiatric health, as well as composite scores. In addition
to the ASI, we recorded the following data from the
case notes: dates of key events (intake, referral, retention
in treatment, treatment sessions, treatment length, and
termination) and documentation of the use of clinical
treatment guidelines. All data were entered in a clinical
information system to support reporting and decision-
making, and were analyzed via SPSS software.
The audit team reviewed retention and outcome data
and random treatment courses qualitatively every 6 months.
The audit team could decide whether or not new standards
should be developed and implemented by other working
groups. The present study describes the evaluation of the
first five standards.
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The study population included two consecutive cohorts
of patients entering psychosocial treatment at the four
alcohol outpatient clinics during either a 6-month pre-
pathway period (Cohort one) or a 6-month post-pathway
period (Cohort two). All patients were included in the
study except those who: were under 18 years old, had se-
vere psychosis or cognitive impairment, did not have a
primary alcohol problem, or were not of Danish origin.
Data from patients who began treatment more than once
during the periods of data collection were only analyzed in
the first collection period. The two samples consisted of
228 patients in Cohort one and 309 patients in Cohort
two.
Data analyses
Student’s t-test was used for comparing the mean values
of the two cohorts, and Chi2 test was employed for bi-
variate data.
In order to follow potential developments in the level
of implementation of the standards, the post-pathway
period was divided into three time periods before analysis,
each of 2 months’ duration. The analysis focused on a)
retention in care; and b) sensible consumption at treat-
ment termination. The reference group included patients
entering during the pre-pathway period (Cohort one).Table 1 Pre-treatment characteristics and treatment courses o
before and after implementation of the clinical pathway (CP)
Variables Cohort 1 (before CP)
Sociodemographic
Female (%) 27.6
Age (mean) 43.2 (10.5)
Education in yrs (mean) 9.6 (1.5)
Currently cohabiting (%) 46.9
ICD - diagnostic
F10.1. Harmful use (%) 16.2
F10.2. Dependence syndrome (%) 83.8
ASI problem scoresa (mean)
Medical 0.317 (0.336)
Employment 0.557 (0.290)
Alcohol use 0.538 (0.235)
Drug use 0.015 (0.050)
Legal status 0.032 (0.100)
Family/social 0.220 (0.221)
Psychiatric 0.226 (0.227)
Treatment course
Treatment sessions (mean) 6.6 (5.3)
Treatment length in days (mean) 149 (125.6)
Retention in treatment for 6 months (%) 47
aBased on Addiction Severity Index – composite score. Scores vary from 0 (no probLogistic regression models were used to control for sever-
ity of alcohol abuse at initiation of treatment (confounder).
The odds ratio was given with 95 percent confidence limit.
The analysis of outcome was based on intention-to-
treat, irrespective of whether the patients had completed
treatment or not. Although not without limitations [16],
last observation carried forward (LOCF) was used to
address missing data [17]. As level of significance for all
tests, alpha = 0.05 was chosen.
Results
Table 1 shows pre-treatment characteristics and treatment
courses for both cohorts. Of four sociodemographic and
seven ASI variables at baseline, the two cohorts differed
on only one: patients in Cohort two had significantly more
severe alcohol problems at baseline (p = 0.002). There was
no significant difference in treatment courses between the
cohorts.
How well staff adhere to the process standards is crucial
to a quality improvement project like the present one.
Table 2 reports adherence to the five process guidelines in
the three 2-month intervals of the post-pathway period.
For Standards 1–4, average adherence was 58 percent and
varied across time periods. The data describing adherence
to Standard 5 showed how only 24 percent of patients
completed a planned termination of treatment with thef patients referred to outpatient psychosocial treatment
(N = 228) Cohort 2 (after CP) (N = 309) p values
29.4 0.645
44.1 (10.7) 0.364
9.6 (1.5) 0.818
49.2 0.604
13.2 0.459
86.8
0.321 (0.351) 0.954
0.540 (0.302) 0.496
0.604 (0.238) 0.002
0.012 (0.046) 0.052
0.028 (0.083 0.978
0.217 (0.236) 0.453
0.219 (0.219) 0.685
6.1 (4.7) 0.234
144 (121.9) 0.612
40 0.326
lem) to 1 (extreme problem) in preceding 30 days.
Table 2 Adherence with process standards
Process standards (Share of patients where standards were followed)
0-2 months after
implementation of
CP (N = 107) %
3-4 months after
implementation of
CP (N = 104) %
5-6 months after
implementation of
CP (N = 98) %
Standard 1: Percent of patients where therapist’s adherence
to the clinical guidelines has been documented.
55 59 64
Standard 2: Percent of patients who are advised or given
information about alcohol disorders.
55 48 53
Standard 3: Percent of patients discussed at team meetings
every 3 months (continuity of care).
58 50 72
Standard 4: Percent of patients where therapist adheres to
standards for retention in care.
64 57 63
Standard 5: Percent of patients who complete the phase of
termination with the therapist.
30 18 24
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improved significantly during the 6-month post-pathway
period was Standard 3 (continuity of care), which improved
from 58 percent to 72 percent, a 24-percent increase;
p = 0.03.
Despite modest staff adherence and no overall change
in retention, patients in Cohort two were substantially
more likely to have a good clinical outcome [see Figure 2;
OR= 1.9 (1.2–3.1)], with a pattern of improvement through-
out post-implementation monitoring. Patients in Co-
hort two also showed significantly higher decreases in
alcohol problem severity on the ASI during treatment
(see Table 3). Furthermore, patients with a good clinical
outcome in terms of sensible consumption also showed
fewer problems in the areas of alcohol, drug, family/social
network, and psychiatric health at the end of treatment2,0
0,9
4,0
6,0
8,0
0,1
1,0
10,0
COHORT 1
(n=228)
0-2 mth.
(n=107)
3-4 mth.
(n=104)
5-6 mth.
(n=98)
Odds ratio
Time after implementation of CP
1Reference group is Cohort 1, before Clinical Pathway, adjusted for 
confounders by logistic regression.
Cohort 1 (reference) Cohort 2, 0-2 mth Cohort 2, 3-4 month   Cohort 2, 4-6 month
(n=228)                             107) (n=104)                             (n=98)
O
A
Figure 2 Changes in outcome indicators concerning retention and se
treatment. 2A Odds ratio1 (95% CL) for retention in care during the first 6
clinical outcome2 (LOCF).than those who did not, measured by the means of ASI
composite scores (not shown in the tables).Discussion
Several studies have found how the use of clinical guide-
lines improves treatment effectiveness and enhances the
implementation of evidence-based methods [18], and that
continuity in treatment is linked to the likelihood of good
outcomes [19]. In a post-only evaluation, the Network for
the Improvement of Addiction Treatment demonstrated
that process improvement strategies can contribute to en-
hanced quality of care for alcohol disorders [20], including
an increase in patient compliance [21]. We did not find
an improvement in retention, but observed a significant
increase in good clinical outcomes and a reduction in0,1
1,0
10,0
2,0
0,9
4,0
6,0
8,0
1Reference group is Cohort 1, before Clinical Pathway, adjusted for 
confounders by logistic regression.
2 Sensible alcohol use (abstinent or drinking no more than 21 standard 
drinks per week over the final months before end of treatment). 
Time after implementation of CP
Cohort 1 (reference) Cohort 2, 0-2 mth Cohort 2, 3-4 month   Cohort 2, 4-6 month
(n=228)                             (n=107) (n=104)                             (n=98)
dds ratio
B
nsible alcohol use in patients referred to individual psychosocial
months of psychosocial treatment. 2B Odds ratio1 (95% CL) for good
Table 3 Change from baseline in Addiction Severity Index (ASI) composite scores and self-reported drinking among
patients treated before and after implementation of the clinical pathway (CP)1 intention-to-treat-analyses (LOCF)
Cohort 1 (before CP) N = 228 Cohort 2 (after CP) N = 309 Difference2 P-values
ASI-composite scores3
•Medical −0.030 (0,256) +0.007 (0.291) +0.023 0.116
•Employment −0.021 (0.165) +0.006 (0.163) +0.015 0.058
•Alcohol use −0.223 (0.261) −0.274 (0.280) −0.051 0.029
•Drug use +0.010 (0.211) −0.005 (0.037) −0.015 0.217
•Legal status −0.014 (0.079) −0.018 (0.080) −0.004 0.567
•Family/social −0.047 (0.196) −0.048 (0.187) −0.001 0.930
•Psychiatric −0.006 (0.218) −0.007 (0.184) −0.002 0.538
Self-reported drinking4
•Abstinent (days) +5.0 (11.6) +9.0 (11.6) +4.0 0.001
•< 4 drinks per day +6.9 (10.4) +9.3 (71.6) +2.4 0.012
•Sensible consumption (%) +31.6 +41.1 +9.5 0.024
1Values are mean (SD).
2Difference between groups, 12 months after initiation of treatment.
3Scores vary from 0 (no-problem) to 1 (extreme problem) in the preceding 30 days.
4Based on ASI the preceding 30 days.
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pathway.
It is a clear limitation to this study that we do not know
to what extent the elements of the standards were met be-
fore the clinical pathway was implemented. We know that
implementation of the clinical pathway was not entirely
successful, in that none of the process standards were met
more than 72 percent of the time. There is much room for
improvement in adherence to the practice standards, but
since a strong focus was placed on implementation during
the post-pathway period, the findings might reflect the
low level of implementation of the various elements in the
pre-pathway period. Difficulties in implementing strategies
are well known and are described in studies of clinical
pathways in the field of psychiatry. Barriers to successful
implementation may include lack of awareness, lack of
agreement, little expectancy of improved outcome, and
inertia [22,23]. Smaller institutions may also need more
time before improvement strategies show effect [21], as
demonstrated in other studies in similar areas [24,25].
In other words, results from the implementation of clinical
pathways in alcohol treatment appear to be as divergent as
those in other health services [26].
Clearly, there are further limitations to this study. We
used the principles of intention-to-treat and, in conse-
quence, included all consecutive patients who started
treatment. We also used the LOCF method; hence, pa-
tients who provided no further data at follow-up were
assigned their pre-test data. Thus, patients who dropped
out of treatment during the first 3 months had their base-
line data allocated as outcome status; patients who dropped
out of treatment before the 6-month status had the data
obtained at the 3-month status interviews allocated asoutcome data, and so on. The LOCF method is, however,
not without problems either, and may lead to biased re-
sults [16]. Furthermore, the quasi-experimental design
relied on a historical control group (Cohort one), with
12 months intervening between the samples. Thus, it is
possible that changes other than the implementation of
the clinical pathway may have accounted for the improve-
ment in client outcomes during the interval.
Within these limitations, this study offers further support
for the effectiveness of a clinical pathway in improving cli-
ent outcomes. We believe that the local introduction of a
clinical pathway can be an effective strategy for microsys-
tems, such as small alcohol treatment clinics to standardize
their processes and reduce clinical performance variations.
The process of having an audit team continuously oversee-
ing data on retention and outcome and, when necessary,
initiating staff working groups to adjust old standards or
develop new ones in the treatment course may be a route
to securing local ownership of the process. In fact, it has
for several years now been a routine practice in the treat-
ment organization under study and serves as a strategy to
open “the closed doors” of the therapists. It is not only
considered to have improved the outcome of treatment, it
is also deemed to have made the treatment much more
transparent and of more uniform quality across the clinics.Competing interests
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